Evaluation of a Community Health Program for the Prevention of Type 2 Diabetes and Other Cardio-metabolic Risk Factors in Adults: Districts of Barranquilla and Bogota, Colombia - January 2017 - December 2019
PREDICOL
1 other identifier
interventional
650
1 country
2
Brief Summary
The main aim of this study is to evaluate the feasibility and effectiveness of a program for modifying lifestyles for diabetes prevention type 2 and control cardio-metabolic risk factors in adults with different categories of risk from the primary health care strategy. The project will show the effect of these interventions for the first time in people With different risk of developing type 2 diabetes throughout the life in populations living in Colombia Located in 2 different cities, one of them in the interior of the country (districts of Bogota) and another in the north coast (districts of Barranquilla) .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2017
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 21, 2016
CompletedFirst Posted
Study publicly available on registry
February 10, 2017
CompletedStudy Start
First participant enrolled
August 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2019
CompletedMarch 12, 2019
March 1, 2019
2.2 years
October 21, 2016
March 8, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Reduction of body weight average at year-end structured intervention compared with the baseline.
Reduction of body weight in kilograms
12 Months
Secondary Outcomes (3)
Reduction of fasting glucose level at year-end intervention program (all groups) compared with baseline.
12 Months
Reduction of 2-hour glucose level at year-end structured and informative intervention program compared with baseline.
12 Months
Reduced of waist circumference average at year-end structured intervention program compared with baseline.
12 Months
Study Arms (3)
Intervention_ structured
EXPERIMENTALOne year Structured intervention program for members of high-risk group (People with glucose intolerance in the OGTT and FINDRISC score ≥12 points) 10 educational group sessions where they will receive information to change lifestyle (1 per 1.5 month)
Intervention_ Informative
EXPERIMENTALProgram information intervention for the group with moderate risk. One year Informative intervention program (People with normotolerant or impaired fasting glucose in the OGTT and FINDRISC score ≥12 points). There is a single group session where they receive information to prevent cardiomatabolic risk factors
Intervention_ Communitarian
EXPERIMENTALOne year, Intervention program at Community level. People with a FINDRISC less than 12 points. Campaigns are carried out at the community level with different strategies (leaflets, booklets) to prevent cardiomatabolic risk factors
Interventions
One year Structured intervention program for members of high-risk group (Subjects with FINDRISC score ≥12 points and impaired glucose tolerance (IGT))
One year Informative intervention program for members of moderate risk group (People with normotolerant or impaired fasting glucose in the OGTT and a FINDRISC score ≥12 points)
One year, Intervention program at Community level. People with a FINDRISC less than 12 points
Eligibility Criteria
You may qualify if:
- People over age 30 years, residents within the perimeter of the conglomerate in the districts of Barranquilla and Bogota
- Wishing to participate and sign informed consent
You may not qualify if:
- DT2 known and / or treated
- History of diseases or events that prevent their participation
- Neurological disability that does not allow you to make own decisions
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Universidad Del Norte
Barranquilla, Colombia
Asociación Colombiana de Diabetes
Bogotá, Colombia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tania Acosta, MD, MPH
Universidad del Norte
- PRINCIPAL INVESTIGATOR
Pablo Achner, MD, ENDOCRINOLOGIST
ASOCIACIÓN COLOMBIANA DE DIABETES
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 21, 2016
First Posted
February 10, 2017
Study Start
August 1, 2017
Primary Completion
October 30, 2019
Study Completion
December 30, 2019
Last Updated
March 12, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share